U-CRC PhD AND POSTDOC ON EPIGENETICS/CANCER (Brussels)

U-CRC
LABORATORY OF CANCER EPIGENETICS
PhD AND POSTDOC
ON EPIGENETICS/CANCER (Brussels)
Job description:
A position is available for a highly motivated student or PhD that wishes to join the Laboratory of
Cancer Epigenetics headed by Prof. François Fuks (ULB-Cancer Research Center, Brussels).
You will be expected to conduct cancer research in epigenetics and epigenomics. Specifically, you
will investigate the mechanisms and functions of a novel epigenetic modification, which our lab
recently investigated (Delatte et al., Science 2016). Genetic, biochemical and cell biological as well
as genome-wide approaches (e.g. RNA-Seq, ChIP-Seq, Infinium Methylation) will be applied. The
lab is running a Next Generation Sequencing platform: EPICS (http://epics.ulb.be/) and is part of
the ULB-Cancer Research Center (U-CRC), providing a high profile scientific environment.
Profile/Starting date:
- PhD: candidates should have a good first degree (BSc or MSc) in Biology, Genetics, Biochemistry
or related. The PhD will be funded by the Belgian FNRS.
- Postdoc: Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related
disciplines (or have recently submitted their thesis with their defence scheduled) and have published
(or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an
asset. The position is funded for 3 years.
For both positions, screening of applications begins immediately and continues until an outstanding
candidate is selected (flexible starting date).
How to apply?:
Informal enquiries, a CV (including grades and ranking for PhD applicant) and names of two
referees should be send to: Valentina Albarani ([email protected]).
Lab website: http://www.ulb.ac.be/medecine/fukslab
Lab NGS platform: http://epics.ulb.be/
Selected publications:
- Delatte et al. Science 2016
- Boumahdi et al. Nature 2014
- Deplus et al. Cell Rep. 2014
- Delatte et al. EMBO J. 2014
- Deplus et al. EMBO J. 2013
- Volkmar et al. EMBO J. 2012
- Dedeurwaerder et al. EMBO Mol Med. 2011
- Fuks F. Nature 2010
- Villa et al. Cancer Cell 2007
- Viré et al. Nature 2006